Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Endocrinology 159 , 34463457 (2018)
In a recent randomized, double-blind, placebo-controlled clinical trial, Quer supplementation (500 mg/day, P.O for 8 weeks) evidently improved serum total antioxidant capacity (TAC) in postmyocardial infarction patients compared to the placebo group [126]
To assess the half maximal inhibitory concentration (IC50) of FOXO4-DRI on the serum limitation-induced senescent fibroblast and the non-senescent control fibroblast, the fibroblast viability in the 2% FBS induced senescent fibroblast and 10% FBS cultured non-senescent control fibroblast with increasing concentrations of FOXO4-DRI was detected, and the cell viability curves were showed in Supplementary Fig
For reconstituted solutions , also store them at 28C and use them within 30 days
Panelists: Hilke Schellmann is an Emmy-award-winning journalism professor at New York University and a freelance reporter holding artificial intelligence accountable
US$ 22.89
US$ 20.83
US$ 28.46
US$ 24.24
US$ 22.85
US$ 22.04
US$ 24.04
